一项涉及回忆疗法的项目对癌症患者焦虑、抑郁及生活质量的影响：随机对照试验的荟萃分析
Effects of a reminiscence therapy-involved program on anxiety, depression, and the quality of life in cancer patients: a meta-analysis of randomized controlled trials.
作者信息
Sun Xingliang, Su Wenlian, Yin Mengyue, Xia Ling
机构信息
Department of Rehabilitation Medicine, Zibo Central Hospital, Zibo, China.
出版信息
Front Psychol. 2024 Sep 17;15:1408941. doi: 10.3389/fpsyg.2024.1408941. eCollection 2024.
OBJECTIVE
Reminiscence therapy is increasingly being utilized for cancer patients to address psychological pressure and enhance their quality of life. This meta-analysis aimed to comprehensively evaluate the effect of a reminiscence therapy-involved program (RTIP) on anxiety, depression, and quality of life in cancer patients.
METHODS
A systematic literature search was conducted in the Web of Science, PubMed, Embase, and Cochrane Library databases until December 2023 to screen randomized control trials (RCTs) comparing the effect of RTIP and control care.
RESULTS
A total of 16 RCTs published from 2013 to 2023 were included, with 1,963 cancer patients undergoing RTIP with or without control care (RTIP group, = 984) or control care (control group, = 979). The results showed the the anxiety score [standardized mean differences (SMD) = -0.539; 95% confidence interval (CI) = -0.700, -0.378; < 0.001], anxiety rate [relative risk (RR) = 0.736; 95% CI: 0.627, 0.865; < 0.001], depression score (SMD = -0.664; 95% CI: -0.967, -0.361; < 0.001), and depression rate (RR = 0.632; 95% CI = 0.532, 0.750; < 0.001) were significantly reduced in the RTIP group compared to the control group. Furthermore, overall quality of life was increased in the RTIP group than in the control group (SMD = 0.501; 95% CI: 0.314, 0.689; < 0.001). In digestive system cancer patients, anxiety/depression scores and rates were reduced, and the overall quality of life was elevated in the RTIP group in comparison with the control group (all < 0.050). The quality of evidence was generally high, with a low risk of bias in most studies and no publication bias in any outcomes (all > 0.050).
CONCLUSION
RTIP attenuates anxiety and depression and improves the quality of life in cancer patients, benefitting their overall health condition.
SYSTEMATIC REVIEW REGISTRATION
This meta-analysis was registered at PROSPERO with registration number CRD42024563266.
目的
回忆疗法越来越多地被用于癌症患者，以应对心理压力并提高他们的生活质量。本荟萃分析旨在全面评估包含回忆疗法的项目（RTIP）对癌症患者焦虑、抑郁和生活质量的影响。
方法
在Web of Science、PubMed、Embase和Cochrane图书馆数据库中进行系统的文献检索，直至2023年12月，以筛选比较RTIP与对照护理效果的随机对照试验（RCT）。
结果
共纳入2013年至2023年发表的16项RCT，1963例癌症患者接受了有或无对照护理的RTIP（RTIP组，n = 984）或对照护理（对照组，n = 979）。结果显示，与对照组相比，RTIP组的焦虑评分[标准化均数差（SMD）=-0.539；95%置信区间（CI）=-0.700，-0.378；P<0.001]、焦虑率[相对危险度（RR）=0.736；95%CI：0.627，0.865；P<0.001]、抑郁评分（SMD=-0.664；95%CI：-0.967，-0.361；P<0.001）和抑郁率（RR=0.632；95%CI = 0.532，0.750；P<0.001）均显著降低。此外，RTIP组的总体生活质量高于对照组（SMD = 0.501；95%CI：0.314，0.689；P<0.001）。在消化系统癌症患者中，与对照组相比，RTIP组的焦虑/抑郁评分和发生率降低，总体生活质量提高（均P<0.050）。证据质量总体较高，大多数研究的偏倚风险较低，任何结局均无发表偏倚（均P>0.050）。
结论
RTIP可减轻癌症患者的焦虑和抑郁，提高其生活质量，有益于他们的整体健康状况。
系统评价注册
本荟萃分析已在PROSPERO注册，注册号为CRD42024563266。
Zotero 插件